/ISOLF

ISOLF Stock - Isodiol International Inc.

Q: What is the analyst price target for ISOLF?

Analyst price target information is not currently available for ISOLF.

Q: What is ISOLF's market cap?

Market capitalization information is not currently available for ISOLF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ISOLF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2015

FY2016

FY2017

FY2018

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.20

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2018	FY2017	FY2016	FY2015
Revenue	$16.65M	$14.84M	$266,905	$12,976
Gross Profit	$-4,054,914	$-1,900,166	$95,014	$8,022.581
Gross Margin	-24.3%	-12.8%	35.6%	61.8%
Operating Income	$-29,229,739	$-18,077,572	$-2,589,135	$-1,914,213
Net Income	$-90,282,899	$-27,939,617	$-3,213,933	$-6,708,285
Net Margin	-542.1%	-188.2%	-1204.1%	-51697.6%
EPS	$-2.35	$-1.33	$-1.01	$-4.53

Company Overview

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.

Visit Website

Frequently Asked Questions about ISOLF

What is ISOLF's current stock price?

Isodiol International Inc. (ISOLF) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for ISOLF?

No analyst price targets are currently available for this stock.

What sector is Isodiol International Inc. in?

Isodiol International Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is ISOLF's market cap?

Isodiol International Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does ISOLF pay dividends?

No, Isodiol International Inc. does not currently pay a dividend to shareholders.